Transcriptional Networks Identify BRPF1 as a Potential Drug Target Based on Inflammatory Signature in Primary Lower-Grade Gliomas
Gliomas are the most common tumors of the central nervous system and are classified into grades I-IV based on their histological characteristics. Lower-grade gliomas (LGG) can be divided into grade II diffuse low-grade gliomas and grade III moderate gliomas and have a relatively good prognosis. Howe...
Main Authors: | Mingyang Xia, Huiyao Chen, Tong Chen, Ping Xue, Xinran Dong, Yifeng Lin, Duan Ma, Wenhao Zhou, Wei Shi, Hao Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.766656/full |
Similar Items
-
Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
by: Qiang Zhang, et al.
Published: (2021-07-01) -
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
by: Hongbo Zhang, et al.
Published: (2020-12-01) -
Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
by: Xiangyang Deng, et al.
Published: (2019-11-01) -
Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients
by: Jin-Cheng Guo, et al.
Published: (2021-03-01) -
A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
by: Yi Zhou, et al.
Published: (2023-11-01)